No retraction, correction or concern found when last checked on Oct 20, 2026.

Carbon Ion Radiobiology

Walter Tinganelli, Marco Durante

Cancers · 2020 · Review · CC BY

doi:10.20944/preprints202010.0055.v1

Abstract

Simple Summary. Radiotherapy with carbon ions has been used for over 20 years in Asia and Europe and is now planned in the USA. The physics advantages of carbon ions compared to X-rays are similar to those of protons, but their radiobiological features are quite distinct and may lead to a breakthrough in the treatment of some cancers characterized by high mortality.

Abstract. Radiotherapy using accelerated charged particles is rapidly growing worldwide. About 85% of the cancer patients receiving particle therapy are irradiated with protons, which have physical advantages compared to X-rays but a similar biological response. In addition to the ballistic advantages, heavy ions present specific radiobiological features that can make them attractive for treating radioresistant, hypoxic tumors. An ideal heavy ion should have lower toxicity in the entrance channel (normal tissue) and be exquisitely effective in the target region (tumor). Carbon ions have been chosen because they represent the best combination in this direction. Normal tissue toxicities and second cancer risk are similar to those observed in conventional radiotherapy. In the target region, they have increased relative biological effectiveness and a reduced oxygen enhancement ratio compared to X-rays. Some radiobiological properties of densely ionizing carbon ions are so distinct from X-rays and protons that they can be considered as a different “drug” in oncology, and may elicit favorable responses such as an increased immune response and reduced angiogenesis and metastatic potential. The radiobiological properties of carbon ions should guide patient selection and treatment protocols to achieve optimal clinical results.

References 322

1.
Wilson R.R. Radiological use of fast protons. Radiology. 1946;47:487-491.
Not in our library10.1148/47.5.487
2.
Tobias C.A. Failla Memorial lecture. The future of heavy-ion science in biology and medicine. Radiat. Res. 1985;103:1-33.
Not in our library10.2307/3576668
3.
Durante M., Paganetti H. Nuclear physics in particle therapy: A review. Rep. Prog. Phys. 2016;79:096702.
Not in our library10.1088/0034-4885/79/9/096702
4.
Schardt D., Elsässer T., Schulz-Ertner D. Heavy-ion tumor therapy: Physical and radiobiological benefits. Rev. Mod. Phys. 2010;82:383-425.
Not in our library10.1103/revmodphys.82.383
5.
Durante M., Cucinotta F.A. Physical basis of radiation protection in space travel. Rev. Mod. Phys. 2011;83:1245-1281.
Not in our library10.1103/revmodphys.83.1245
6.
Sørensen B.S., Overgaard J., Bassler N. In vitro RBE-LET dependence for multiple particle types. Acta Oncol. 2011;50:757-762.
Not in our library10.3109/0284186x.2011.582518
7.
Friedrich T., Scholz U., Elsässer T., Durante M., Scholz M. Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation. J. Radiat. Res. 2013;54:494-514.
Not in our library10.1093/jrr/rrs114
8.
Blakely E.A., Ngo F., Curtis S., Tobias C.A. Heavy-ion radiobiology: Cellular studies. Adv. Radiat. Biol. 1984;11:295-389.
Not in our library10.1016/b978-0-12-035411-5.50013-7
9.
Durante M. New challenges in high-energy particle radiobiology. Br. J. Radiol. 2014;87:20130626.
Not in our library10.1259/bjr.20130626
10.
Skarsgard L.D. Radiobiology with heavy charged particles: A historical review. Phys. Medica. 1998;14(Suppl. 1):1-19.
Not in our library
11.
Durante M., Loeffler J.S. Charged particles in radiation oncology. Nat. Rev. Clin. Oncol. 2010;7:37-43.
Not in our library10.1038/nrclinonc.2009.183
12.
Durante M. Eighth Warren K. Sinclair Keynote Address: Heavy Ions in Therapy and Space: Benefits and Risks. Health Phys. 2012;103:532-539.
Not in our library10.1097/hp.0b013e318264b4b6
13.
Castro J.R. Results of heavy ion radiotherapy. Radiat. Environ. Biophys. 1995;34:45-48.
Not in our library10.1007/bf01210545
14.
Horsman M.R., Mortensen L.S., Busk M., Overgaard J., Horsman M.R., Mortensen L.S., Petersen J.B., Busk M., Overgaard J. Imaging hypoxia to improve radiotherapy outcome. Nat. Rev. Clin. Oncol. 2012;9:674-687.
Not in our library10.1038/nrclinonc.2012.171
15.
Tommasino F., Scifoni E., Durante M. New Ions for Therapy. Int. J. Part. Ther. 2015;2:428-438.
Not in our library10.14338/ijpt-15-00027.1
16.
Tsujii H., Kamada T., Shirai T., Al. E., Tsujii H., Kamada T., Shirai T., Noda K., Tsuji H., Karasawa K. Carbon-Ion Radiotherapy. 2014.
Not in our library
17.
Kamada T., Tsujii H., Blakely E.A., Debus J., De Neve W., Durante M., Jäkel O., Mayer R., Orecchia R., Pötter R., et al. Carbon ion radiotherapy in Japan: An assessment of 20 years of clinical experience. Lancet Oncol. 2015;16:e93-e100.
Not in our library10.1016/s1470-2045(14)70412-7
18.
Kraft G. Tumor therapy with heavy charged particles. Prog. Part. Nucl. Phys. 2000;45:473-544.
Not in our library10.1016/s0146-6410(00)00112-5
19.
Amaldi U., Kraft G. Radiotherapy with beams of carbon ions. Rep. Prog. Phys. 2005;68:1861-1882.
Not in our library10.1088/0034-4885/68/8/r04
20.
Brower V. Carbon Ion Therapy To Debut in Europe. JNCI J. Natl. Cancer Inst. 2009;101:74-76.
Not in our library10.1093/jnci/djn496
21.
Carbon Ion Therapy: A Modern Review of an Emerging Technology · 2020
No notice
22.
Pompos A., Durante M., Choy H. Heavy Ions in Cancer Therapy. JAMA Oncol. 2016;2:1539.
Not in our library10.1001/jamaoncol.2016.2646
23.
Bortfeld T.R., Loeffler J.S. Three ways to make proton therapy affordable. Nature. 2017;549:451-453.
Not in our library10.1038/549451a
24.
Jäkel O., Smith A.R., Orton C.G. The more important heavy charged particle radiotherapy of the future is more likely to be with heavy ions rather than protons. Med. Phys. 2013;40:090601.
Not in our library10.1118/1.4798945
25.
Uhl M., Mattke M., Welzel T., Roeder F., Oelmann J., Habl G., Jensen A., Ellerbrock M., Jäkel O., Haberer T., et al. Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: First long-term results. Cancer. 2014;120:3410-3417.
Not in our library10.1002/cncr.28877
26.
Shinoto M., Yamada S., Terashima K., Yasuda S., Shioyama Y., Honda H., Kamada T., Tsujii H., Saisho H., Asano T., et al. Carbon Ion Radiation Therapy With Concurrent Gemcitabine for Patients With Locally Advanced Pancreatic Cancer. Int. J. Radiat. Oncol. 2016;95:498-504.
Not in our library10.1016/j.ijrobp.2015.12.362
27.
Kawashiro S., Yamada S., Okamoto M., Ohno T., Nakano T., Shinoto M., Shioyama Y., Nemoto K., Isozaki Y., Tsuji H., et al. Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas. Int. J. Radiat. Oncol. 2018;101:1212-1221.
Not in our library10.1016/j.ijrobp.2018.04.057
28.
Shinoto M., Yamada S., Okamoto M., Shioyama Y., Ohno T., Nakano T., Nemoto K., Isozaki Y., Kawashiro S., Tsuji H., et al. Carbon-ion radiotherapy for locally recurrent rectal cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1404 Rectum. Radiother. Oncol. 2019;132:236-240.
Not in our library10.1016/j.radonc.2018.10.007
29.
Durante M., Debus J. Heavy Charged Particles: Does Improved Precision and Higher Biological Effectiveness Translate to Better Outcome in Patients? Semin. Radiat. Oncol. 2018;28:160-167.
Not in our library10.1016/j.semradonc.2017.11.004
30.
Proton Radiobiology · 2015
No notice
31.
Tracy B.L., Stevens D.L., Goodhead D.T., Hill M.A. Variation in RBE for Survival of V79-4 Cells as a Function of Alpha-Particle (Helium Ion) Energy. Radiat. Res. 2015;184:33.
Not in our library10.1667/rr13835.1
32.
Brenner D.J., Sachs R.K. Do low dose-rate bystander effects influence domestic radon risks? Int. J. Radiat. Biol. 2002;78:593-604.
Not in our library10.1080/09553000210121740
33.
Parker C., Lewington V., Shore N., Kratochwil C., Levy M., Lindén O., Noordzij W., Park J., Saad F. Targeted Alpha Therapy, an Emerging Class of Cancer Agents. JAMA Oncol. 2018.
Not in our library10.1001/jamaoncol.2018.4044
34.
La Tessa C., Sivertz M., Chiang I.H., Lowenstein D., Rusek A. Overview of the NASA space radiation laboratory. Life Sci. Space Res. 2016;11:18-23.
Not in our library10.1016/j.lssr.2016.10.002
35.
Walsh L., Schneider U., Fogtman A., Kausch C., McKenna-Lawlor S., Narici L., Ngo-Anh J., Reitz G., Sabatier L., Santin G., et al. Research plans in Europe for radiation health hazard assessment in exploratory space missions. Life Sci. Space Res. 2019;21:73-82.
Not in our library10.1016/j.lssr.2019.04.002
36.
Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys. Med. Biol. 2014;59:R419-R472.
Not in our library10.1088/0031-9155/59/22/r419
37.
Underwood T.S.A., Grassberger C., Bass R., MacDonald S.M., Meyersohn N.M., Yeap B.Y., Jimenez R.B., Paganetti H. Asymptomatic Late-phase Radiographic Changes Among Chest-Wall Patients Are Associated with a Proton RBE Exceeding 1.1. Int. J. Radiat. Oncol. 2018;101:809-819.
Not in our library10.1016/j.ijrobp.2018.03.037
38.
Haas-Kogan D., Indelicato D., Paganetti H., Esiashvili N., Mahajan A., Yock T., Flampouri S., MacDonald S., Fouladi M., Stephen K., et al. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. Int. J. Radiat. Oncol. 2018;101:152-168.
Not in our library10.1016/j.ijrobp.2018.01.013
39.
Paganetti H., Blakely E., Carabe-Fernandez A., Carlson D.J., Das I.J., Dong L., Grosshans D., Held K.D., Mohan R., Moiseenko V., et al. Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. Med. Phys. 2019;46:e53-e78.
Not in our library10.1002/mp.13390
40.
Lea D.E. Action of Radiations on Living Cells. 1947.
Not in our library

All 322 references

Cited by papers we hold 1

Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts · 2021
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.